Cloning of human NKp44 gene and its expression and purification in E. coli
Zhao Yue-ran
Abstract
Zhao Yue-ran
Abstract
OBJECTIVE:To clone the gene of human NKp44 and express the recombinant human NKp44 in E.coli in order to provide a basis for further study of antitumor immune response of NK cells.METHODS:Peripheral blood mononuclear cells(PBMC)were prepared from a health volunteer's peripheral venous blood,cultured and introduced by IL-2.Total RNA was isolated from PBMC.A hNKp44 DNA fragment,with a length of about 860 bp,was amplified from the total RNA by nested PCR and cloned to plasmid pMD18-T,and the cloned DNA fragment was sequenced.The recombinant plasmid pMD18-T-hNKp44 was digested with EcoRⅠ and NcoⅠ,then hNKp44 fragment was isolated and inserted to the corresponding restriction site on procaryotic expression vector pET30a(+).The recombinant plasmid pET30a(+)-hNKp44 was identified by restriction analysis and transformed to E.coli BL21(DE3),and then its expression was induced by IPTG.The expressed product was identified by SDS-PAGE and Western Blotting.The expressed protein was purified by His·Bind Purification Kit.RESULTS:The length of DNA fragment amplified by nested PCR was consistent with that of hNKp44 cDNA.DNA sequencing of pMD18-T-hNKp44 revealed that the cloned DNA sequence was identical to that of reported hNKp44 cDNA.SDS-PAGE proved that expressed product,with a relative molecular weight of 35.4×103,contained about 40% of total somatic protein.Western Blot showed that the recombinant protein could specifically bind to anti-His·Tag antibody.The recombinant protein was obtained by purification with 95% of final purity and 40% of recovery rate.CONCLUSION:A recombinant bacterial strain for expressing hNKp44 is successfully constructed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To clone the gene of human NKp44 and express the recombinant human NKp44 in E.coli in order to provide a basis for further study of antitumor immune response of NK cells.METHODS:Peripheral blood mononuclear cells(PBMC)were prepared from a health volunteer's peripheral venous blood,cultured and introduced by IL-2.Total RNA was isolated from PBMC.A hNKp44 DNA fragment,with a length of about 860 bp,was amplified from the total RNA by nested PCR and cloned to plasmid pMD18-T,and the cloned DNA fragment was sequenced.The recombinant plasmid pMD18-T-hNKp44 was digested with EcoRⅠ and NcoⅠ,then hNKp44 fragment was isolated and inserted to the corresponding restriction site on procaryotic expression vector pET30a(+).The recombinant plasmid pET30a(+)-hNKp44 was identified by restriction analysis and transformed to E.coli BL21(DE3),and then its expression was induced by IPTG.The expressed product was identified by SDS-PAGE and Western Blotting.The expressed protein was purified by His·Bind Purification Kit.RESULTS:The length of DNA fragment amplified by nested PCR was consistent with that of hNKp44 cDNA.DNA sequencing of pMD18-T-hNKp44 revealed that the cloned DNA sequence was identical to that of reported hNKp44 cDNA.SDS-PAGE proved that expressed product,with a relative molecular weight of 35.4×103,contained about 40% of total somatic protein.Western Blot showed that the recombinant protein could specifically bind to anti-His·Tag antibody.The recombinant protein was obtained by purification with 95% of final purity and 40% of recovery rate.CONCLUSION:A recombinant bacterial strain for expressing hNKp44 is successfully constructed.
Key concepts: Recombinant DNA, Molecular biology, Biology, Complementary DNA, Plasmid, Gene, Molecular cloning, DNA